The Current Ratio as of December 2025 (TTM) for Santhera Pharmaceuticals Holding AG (SPHDF) is 1.02

According to Santhera Pharmaceuticals Holding AG’s latest financial reports and current stock price. The company's current Current Ratio is 1.02. This represents a change of -0.15% compared to the average of 1.02 of the last 4 quarters.

Santhera Pharmaceuticals Holding AG (SPHDF) Historical Current Ratio (quarterly & annually)

How has SPHDF Current Ratio performed in the past?

The mean historical Current Ratio of Santhera Pharmaceuticals Holding AG over the last ten years is 3.21. The current 1.02 Current Ratio has changed 3.07% with respect to the historical average. Over the past ten years (40 quarters), SPHDF's Current Ratio was at its highest in in the December 2006 quarter at 14.92. The Current Ratio was at its lowest in in the June 2006 quarter at 0.

Santhera Pharmaceuticals Holding AG (SPHDF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Santhera Pharmaceuticals Holding AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Santhera Pharmaceuticals Holding AG (SPHDF) Average Current Ratio

How has SPHDF Current Ratio performed in the past?

The current Current Ratio of Santhera Pharmaceuticals Holding AG (SPHDF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Santhera Pharmaceuticals Holding AG (SPHDF) Current Ratio vs. Peers

How is SPHDF’s Current Ratio compared to its peers?

Santhera Pharmaceuticals Holding AG’s Current Ratio is less than Genfit S.A. (3.74), less than JW (Cayman) Therapeutics Co. Ltd (1.59), less than Silence Therapeutics plc (7.69), less than Molecular Partners AG (9.35), less than Brii Biosciences Limited (42.98), less than Botanix Pharmaceuticals Limited (4.00), less than Innate Pharma S.A. (2.21), greater than NDT Pharmaceuticals Inc. (0.01), less than Oryzon Genomics S.A. (2.62), greater than NervGen Pharma Corp. (0.92),

Build a custom stock screener for Santhera Pharmaceuticals Holding AG (SPHDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santhera Pharmaceuticals Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santhera Pharmaceuticals Holding AG (SPHDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santhera Pharmaceuticals Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.